Nope!Honestly religion is less contentious than politics these days. If you want to discuss the various sects of Protestantism have at it.

Nope!Honestly religion is less contentious than politics these days. If you want to discuss the various sects of Protestantism have at it.
Am I oversimplifying? Definitely. If you wanted a more detailed explanation, you'd have to ask a person with more knowledge. I have never taken an economics course. Is it a false dichotomy? Although this is speculation, it's my opinion that without companies making huge profits, these drugs and many others wouldn't have been developed. This is speculative because our current system produced these drugs. Can I say with certainty that a truly socialist system wouldn't have produced drugs as effective as these? I cannot. My own economic beliefs tend towards support for capitalism. I'm toying with the idea that the US should limit the amounts that people can be charged for drugs. The amounts would be based upon some conception of a reasonable return. Such restrictions would reduce the amount invested in pharmaceutical development. That's why it's important not to cut too much. I also worry that once government takes this over that it will create a worse system that what we have now.False dichotomy. We both know that itās much more complicated than this simplistic AM talk radio host explanation.
I am not shilling for Lilly either, they are a for profit company whose goal is to profit. That being said, drug patents always last 20 years. Sometimes this seems to vary because the patent is filed before clinical trials and before the drug hits the market. The molecule patent for mounjaro/zepbound expires in 2036 with the delivery system patent expiring in 2039. No pharmaceutical companies give up patent protection early so we likely wonāt see generic versions earlier than 2037. I agree with all that the costs are ridiculous and that they could still make plenty of money if the costs were much lower.Taking emotion out of it. It is Eli Lilly and Novo's patents for both tirzepatide and semaglutide and compound medications were never meant to be permanent. NO, I am not shilling for Lilly, just saying. I mix and match both compound, grey and brand. It all works the same. I will say Eli Lilly expanding their Cash Pay program so vials up to 10mg are now under $499 a month is a start, and more affordable for the general public.
Of course, this was a tactic to showcase availability and the medication not being in shortage.
I do not see how our government's stated goal of harming your healthcare system can help our system. I'd be more upset if I were you, but thank you for your sacrifice!As a European who is very much not a fan of Trump I do support what he'd like to do in the scenario - reduce drug prices for Americans. All of us should have affordable health care. I just wish the method he was choosing to do it was not blame it on the likes of Europeans and suggest the answer is for foreign public health services to pay more to private corporations...